Evidence map›Paper›PMID 34173942›Full record

ReviewHigh blood pressure & cardiovascular prevention : the official journal of the Italian Society of Hypertension2021

Covid and Cardiovascular Diseases: Direct and Indirect Damages and Future Perspective.

Giacomo Ruzzenenti, Alessandro Maloberti, Valentina Giani, Marco Biolcati, Filippo Leidi, Massimiliano Monticelli, Enzo Grasso, Iside Cartella, Matteo Palazzini, Laura Garatti and 5 more

Open access · hybridAbstract readReview
In one paragraph

Review in High blood pressure & cardiovascular prevention : the official journal of the Italian Society of Hypertension, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed, 4 pooled it
2.6field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 4 syntheses or guidelines pooled it, 43 citations in OpenAlex.

  1. Pooled it
  2. Risk of Incident New-Onset Arterial Hypertension After COVID-19 Recovery: A Systematic Review and Meta-analysis.High blood pressure & cardiovascular prevention : the official journal of the Italian Society of Hypertension · 2023
    Pooled it
  3. Pooled it
  4. Pooled it
  5. Observational
  6. Review
  7. Article
  8. Uncovering the toll of the first three COVID-19 waves: excess mortality and social patterns in Belgium.Archives of public health = Archives belges de sante publique · 2024
    Article
  9. A New Biomarker Copeptin in Determining Disease Severity in COVID-19.Infectious diseases & clinical microbiology · 2024
    Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 2 institutions in 1 country.

Giacomo RuzzenentiSchool of Medicine and Surgery, Milano-Bicocca University, Milan, Italy.
Alessandro MalobertiSchool of Medicine and Surgery, Milano-Bicocca University, Milan, Italy. alessandro.maloberti@ospedaleniguarda.it.ORCID http://orcid.org/0000-0002-2612-6264
Valentina GianiSchool of Medicine and Surgery, Milano-Bicocca University, Milan, Italy.
Marco BiolcatiSchool of Medicine and Surgery, Milano-Bicocca University, Milan, Italy.
Filippo LeidiSchool of Medicine and Surgery, Milano-Bicocca University, Milan, Italy.
Massimiliano MonticelliSchool of Medicine and Surgery, Milano-Bicocca University, Milan, Italy.
Enzo GrassoSchool of Medicine and Surgery, Milano-Bicocca University, Milan, Italy.
Iside CartellaSchool of Medicine and Surgery, Milano-Bicocca University, Milan, Italy.
Matteo PalazziniSchool of Medicine and Surgery, Milano-Bicocca University, Milan, Italy.
Laura GarattiSchool of Medicine and Surgery, Milano-Bicocca University, Milan, Italy.
Nicola UghiDivision of Rheumatology, Multispecialist Medical Department, ASTT GOM Niguarda Ca' Granda, Milan, Italy.
Claudio RossettiNuclear Medicine, ASST GOM Niguarda Ca' Granda, Milan, Italy.
Oscar Massimiliano EpisDivision of Rheumatology, Multispecialist Medical Department, ASTT GOM Niguarda Ca' Granda, Milan, Italy.
Cristina GiannattasioSchool of Medicine and Surgery, Milano-Bicocca University, Milan, Italy.
Covid-19 Niguarda Working Group
Ospedale Maggiore · ITAzienda Socio Sanitaria Territoriale Grande Ospedale Metropolitano Niguarda · IT

Funding

Ministero dell'Istruzione, dell'Università e della Ricerca Department of Excellence project PREMIA (PREcision MedIcine Approach: bringing biomarker research to clinic).
6 · The paper itself

Abstract

SARS-CoV-2 infection determines a disease that predominantly affects lungs. However the cytokines storms, determined by the huge immune response to the infection, could affect also other organs and apparatus such as heart and vessels. Beyond the acute inflammation itself also hypercoagulative status has been linked to SARSCoV-2 infection and this surely relates to the increase seen in prevalence of pulmonary embolism and myocardial infarction. A number of cardiac abnormalities and pathologies have been observed, with special attention to cardiac arrhythmias and myocardial involvement. Furthermore, indirect damages determined by the reduction in acute and chronic cardiovascular care, results in a strong mortality and morbidity outcomes in cardiological patients. In this review we will summarise current knowledge on both direct and indirect cardiovascular damages determined by the SARS-CoV-2 pandemia.

Indexed as

Cardiovascular DiseasesCardiovascular SystemCOVID-19COVID-19 VaccinesHost-Pathogen InteractionsHumansPrognosisSARS-CoV-2TelemedicineVaccinationCOVID-19 VaccinesAcute myocardial infarctionCardiovascularCoronavirusCOVID-19MyocarditisSARS-CoV-2

Identifiers

PMID34173942
PMCPMC8233573
OpenAlexW3176940091

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.